Finance: Roche's CEO expresses concerns over the strong Swiss franc while the company increases its investments in the U.S. market.
Currency fluctuations impacted the Swiss drugmaker's earnings in Q1, reflecting challenges in the global market. Stay tuned for how they plan to navigate these financial tides! #Finance #Pharma #Q1Earnings
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
